0001607700-16-000002.txt : 20160216 0001607700-16-000002.hdr.sgml : 20160215 20160216120932 ACCESSION NUMBER: 0001607700-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160216 DATE AS OF CHANGE: 20160216 EFFECTIVENESS DATE: 20160216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KPI Therapeutics, Inc. CENTRAL INDEX KEY: 0001607700 IRS NUMBER: 300786656 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-257506 FILM NUMBER: 161425229 BUSINESS ADDRESS: STREET 1: 219 TERRY AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-378-0400 MAIL ADDRESS: STREET 1: 219 TERRY AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: Kineta Prime Inc. DATE OF NAME CHANGE: 20140509 D 1 primary_doc.xml X0707 D LIVE 0001607700 KPI Therapeutics, Inc. 219 TERRY AVENUE NORTH, SUITE 300 SEATTLE WA WASHINGTON 98109 206-378-0400 DELAWARE Kineta Prime Inc. Corporation true 2013 Charles L. Magness 219 Terry Ave N. Suite 300 Seattle WA WASHINGTON 98109-5208 Executive Officer Director Blake Ilstrup 219 Terry Ave N. Suite 300 Seattle WA WASHINGTON 98109-5208 Executive Officer Craig Philips 219 Terry Ave N. Suite 300 Seattle WA WASHINGTON 98109-5208 Executive Officer Paul Sylvester 219 Terry Ave N. Suite 300 Seattle WA WASHINGTON 98109-5208 Director James G. W. Reed 219 Terry Ave N. Suite 300 Seattle WA WASHINGTON 98109-5208 Director Don Merlino 219 Terry Ave N. Suite 300 Seattle WA WASHINGTON 98109-5208 Director Biotechnology Decline to Disclose 06b false 2016-02-03 false true false 50000 7500000 50500 7449500 false 1 0 0 0 false KPI Therapeutics, Inc. /Blake Ilstrup/ Blake Ilstrup General Counsel 2016-02-16